|
![]() |
|||
|
||||
Overview150 years after the first description of the clinical picture of ""white blood"" and the introduction of the term ""leukemia"" by R. Virchow it appears, that the leukemias, and the acute leukemias in particular, serve as an impressive example for the major improvements that have been achieved in the treatment but also in the understand ing of the biology of malignant dis orders. The international symposia ""Acute Leukemia"" which are held at Münster since 1986 have developed into an interna tional forum to review the current progress and the future perspectives of leukemia research and therapy at a high scientific and clinicallevel. Since the possibility for active participation in these symposia is somewhat restricted we are glad to have the opportunity to extend the information that was presented at the symposium ""Acute Leukemias V - Experimental Approaches and Management of Refractory Disease"" which was held from February 27 to March 2, 1994 to a broader audience of basic scientists and clinicians. This meeting was especiaIly designed to discuss experimen tal approaches and the management of refractory disease which allows to evaluate new experimental therapies on the basis of preclinical studies. Full Product DetailsAuthor: Wolfgang Hiddemann , Thomas Büchner , Bernhard Wörmann , J. RitterPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Edition: Softcover reprint of the original 1st ed. 1996 Volume: 37 Dimensions: Width: 15.50cm , Height: 3.30cm , Length: 23.50cm Weight: 0.973kg ISBN: 9783642789090ISBN 10: 3642789099 Pages: 613 Publication Date: 01 December 2012 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsLeukemia Cell Biology.- Pharmacokinetics — Clinical Implications.- Chemo-Resistance.- Growth Factors — Modulation.- Chemotheraphy in AML.- Chemotherapy in ALL.- Immunotherapy of Acute Leukemias.- Bone Marrow Transplantation.- Novel Therapeutic Approaches.- Residual Disease.- Supportive Care.- Fludarabine in Chronic Lymphocytic Leukemia and Maligant Lymphomas.- Novantrone — Current Status and Future Perspectives.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |